Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05358951 · ClinicalTrials.gov registry record · NA

Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)

A NA study of Cancer and Insomnia, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT05358951 is a NA study of Cancer and Insomnia that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 56 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05358951, a NA study of Cancer and Insomnia, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to learn if a single online education session, with or without individualized coaching sessions, can help improve young adult cancer survivors' (YACS) sleep. The name of the study intervention is Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA).

Interventions

  • BEHAVIORAL STEP-YA with Coaching
  • BEHAVIORAL STEP-YA without Coaching

Study Locations (1)

Massachusetts

  • Dana-Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2022-11-19
Est. Completion 2025-07-28
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT05358951

The ClinicalTrials.gov registry entry for NCT05358951 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which STEP-YA with Coaching is the first listed.

NCT05358951 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05358951 about?

NCT05358951 is a clinical study titled "Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)". The purpose of the study is to learn if a single online education session, with or without individualized coaching sessions, can help improve young adult cancer survivors' (YACS) sleep. The name of the study intervention is Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA...

What is the current status of trial NCT05358951?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2022-11-19. Estimated completion is 2025-07-28.

What conditions does trial NCT05358951 study?

This clinical trial studies the following conditions: Cancer, Insomnia, Insomnia Due to Medical Condition.

What interventions are being tested in trial NCT05358951?

The interventions under investigation include: STEP-YA with Coaching (BEHAVIORAL), STEP-YA without Coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT05358951?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05358951 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.